Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2022-061864
PubMed Identifier: 35428650
Publication URI: http://europepmc.org/abstract/MED/35428650
Type: Journal Article/Review
Volume: 12
Parent Publication: BMJ open
Issue: 4
ISSN: 2044-6055